Document Type : Original Article


1 Department of Health Information Technology, Faculty of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Cardiovascular Research Center, Health Institute,Imam-Ali Hospital, kermanshah University of Medical Sciences, Kermanshah, Iran

3 Department of Nursing Management, Vice Chancellor for Clinical Affairs, Kermanshah University of Medical Sciences, Kermanshah, Iran


Background: Complications are defined as the adverse outcome of the procedures. They increase the length of stay and costs, endanger the patient’s quality of life, and are associated with legal issues. This study aims to analyze the complications of drugs and surgeries in hospitalized patients.
Methods: This descriptive study was conducted on patients hospitalized from 2013 to 2019. Research resources included records of hospitalized patients with Y40-84 codes based on ICD-10 selected by the census. Records numbers were retrieved from HIS based on the code; records were extracted from the archive of an Iranian hospital. Data were collected using a checklist consisting of two parts. First, the characteristics of the patients and second, the cause and type of complications were extracted by studying the records. The data were analyzed using SPSS20
Results: 151 records with Y40-84 codes were retrieved. The records related to complications of procedures and medications were 55 and 96, respectively. 55.6% of patients were female, and 44.4% were male. The average age and length of stay were 51.95 years and 5.7 days, respectively. Post-operative infection and gastrointestinal bleeding, with 49.1% and 20.83%, were the most common complications of surgery and medication, respectively. DVT with 17.2% and cesarean section with 7.3% were the most common cause of complications. Finally, Warfarin had the most complications, with 80%.
Conclusion: Complications lead to increased length of stay, costs, and mortality. Therefore, to prevent them, it is necessary to evaluate the patient’s condition before proceeding, training, and monitoring the treatment process.


  1. Mehrabi Tavana A. Nosocomial Infections: a Global Problem. Hakim Health Sys Res 2016;19(2):100-02.
  2. Sokol DK, Wilson J. What is a surgical complication? World journal of surgery 2008;32(6):942-44. doi: DOI 10.1007/s00268-008-9471-6
  3. Kim SH, Hwang HK, Lee WJ, et al. Comprehensive Complication Index or Clavien–Dindo Classification: Which is Better for Evaluating the Severity of Postoperative Complications Following Pancreatectomy? World Journal of Surgery 2020:1-8.
  4. Fazaeli AA, Fazaeli AA, Hamidi Y, et al. Analysis of iranian household financial participation in the health system: decomposition of the concentration index approach. Koomesh 2018:358-68.
  5. Shojaei S, Yousefi M, Ebrahimipour H, et al. Catastrophic health expenditures and impoverishment in the households receiving expensive interventions before and after health sector evolution plan in Iran: Evidence from a big hospital. Koomesh 2018:283-90.
  6. Yousefi M, Aliani S, Valinejadi A, et al. Effect of" Iran's health system evolution plan" and" tariff change" on financial performance of para-clinic units in a big tertiary hospital in Iran. Koomesh 2018;20(2)
  7. Kabra S, Sinha S, Das S, et al. Effect of Adherence to the World Health Organization Surgical Safety Checklist on Morbidity and Mortality in a Defined Surgical Patient Population. Annals of International Medical and Dental Research 2019;5(4):24.
  8. Macefield RC, Reeves BC, Milne TK, et al. Development of a single, practical measure of surgical site infection (SSI) for patient report or observer completion. Journal of Infection Prevention 2017;18(4):170-79.
  9. Ast MP, Mayman DJ, Su EP, et al. The reduction of implant-related errors and waste in total knee arthroplasty using a novel, computer based, e. Label and compatibility system. The Journal of arthroplasty 2014;29(1):132-36.
  10. Bialkowski W, Tan S, Mast AE, et al. Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage. Thrombosis Research 2020;185:109-18.
  11. Baniasadi S, Habibi M, Haghgoo R, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iranian journal of pharmaceutical research: IJPR 2014;13(1):291.
  12. Abbasi E, Ghazavi A, Valizadeh M, et al. Complications of Antiepileptic Drugs in Hospitalized Patients in Shahid Motahari Hospital of Urmia from 2010 till the end of 2016. Studies in Medical Sciences 2020;31(6):499-506.
  13. Asal Zeinalzadeh. Evaluation of drug interactions of outpatient prescriptions in East Azarbaijan province. Tabriz University of Medical Sciences, 2020.
  14. Wahlang JB, Laishram PD, Brahma DK, et al. Adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital. Therapeutic advances in drug safety 2017;8(2):61-66.
  15. Ramasubbu SK, Pasricha RK, Nath UK, et al. Frequency, nature, severity and preventability of adverse drug reactions arising from cancer chemotherapy in a teaching hospital. Journal of Family Medicine and Primary Care 2020;9(7):3349.
  16. Azar Fani Pakdel, Sepideh Elyasi, Mohamad-Mehdi Kooshyar, et al. Identification and analysis of adverse drug reactions associated with colorectal and gastric cancer chemotherapy in hospitalized patients. Medical Journal of Mashhad 2018;61(2):921-30. doi: 10.22038/mjms.2018.11560
  17. Dashti Z, Mozaffari N, Shamshiri M, et al. Medication Errors and its Reporting by Nurses of Intensive Care Units of Ardabil in 2017. Journal of Health and Care 2019;21(3):184-91.
  18. Sorenson C, Drummond M. Improving medical device regulation: the United States and Europe in perspective. The Milbank Quarterly 2014;92(1):114-50.
  19. Ershad Sarabi R, Mokhtari Z, Naghibzadeh Tahami A, et al. Assessment of type 2 diabetes patients’ self-care status learned based on the national diabetes control and prevention program in health centers of a selected city, Iran. Koomesh 2021;23(4):465-73.
  20. Mohammadi A, Valinejadi A, Sakipour S, et al. Improving the distribution of rural health houses using elicitation and GIS in Khuzestan province (the southwest of Iran). International journal of health policy and management 2018;7(4):336.
  21. Alipour J, Safari Lafti S, Askari Majdabadi H, et al. Factors affecting hospital information system acceptance by caregivers of educational hospitals based on technology acceptance model (TAM): A study in Iran. Iioab Journal 2016:119-23.
  22. Ziari A, Ansari M, Valinejadi A. The gap between the service quality and patients’ expectations in amir-al-momenin hospital of Semnan university of medical sciences in 2016, Semnan, Iran. Koomesh 2018:221-27.
  23. Ansari M, Mohammad-Moradi F, Khaledian M, et al. Assessment of health literacy level in 18-30 year-old adults, an Iranian experience. Library Philosophy and Practice 2018:1850.
  24. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization 2016.
  25. Agrawal A, Singh R. Surgical site infection in abdominal surgeries: A clinical study. Journal of Evolution of Medical and Dental Sciences 2014;3(40):10188-93. doi:
  26. Thombare D, Joshi D. A Study of Incidence and Risk Factors in Post Operative Abdominal Wound Infection in Tertiary Care Centre. MVP Journal of Medical Science 2019;6(1):8-14. doi: DOI: 10.18311/mvpjms/2019/v6i1/18338
  27. Malik AZ. Surgical site infections after elective surgery in Pakistan: Surgipak Study. Journal of Rawalpindi Medical College 2015;19(3):209-14.
  28. Rochon M, Jenkinson S, Ramroop R, et al. Retrospective analysis of the Photo at Discharge scheme and readmission for surgical site infection following coronary artery bypass graft surgery. Journal of Infection Prevention 2018;19(6):270-76.
  29. Hinchliffe R, Earnshaw J. Surgical infection. British Journal of Surgery 2017;104(2):e8-e10. doi: DOI: 10.1002/bjs.10468
  30. Vazin A, Karimzadeh I, Karamikhah R, et al. Clinical and economical impacts of guideline implementation by the pharmaceutical care unit for high cost medications in a referral teaching hospital. BMC health services Research 2018;18(1):1-10. doi: doi: 10.1186/s12913-018-3627-3
  31. Ghallab ET. Post-operative Bleeding and its Management. The Egyptian Journal of Hospital Medicine 2018;70(9):1480-83.
  32. Carol Burke, Roma  Complications of Cesarean Birth, Clinical Recommendations for Prevention and Management. The American Journal of Maternal/Child Nursing 2020;45(2):92-99. doi: doi: 10.1097/NMC.0000000000000598
  33. Sanger PC, Simianu VV, Gaskill CE, et al. Diagnosing surgical site infection using wound photography: a scenario-based study. Journal of the American College of Surgeons 2017;224(1):8-15. e1.
  34. Noormandi A, Karimzadeh I, Mirjalili M, et al. Clinical and economic impacts of clinical pharmacists’ interventions in Iran: a systematic review. DARU Journal of Pharmaceutical Sciences 2019:1-18. doi: 10.1007/s40199-019-00245-8
  35. Duman A, Akoz A, Dagli B, et al. Analysis of patients admitted to the emergency service for warfarin complication and determination of their levels of knowledge and requirements of knowledge about warfarin use. Journal of Experimental and Clinical Medicine 2017;34(4):247-50. doi: doi: 10.5835/jecm.omu.34.04.004
  36. Chen HY, Albertson TE, Olson KR. Treatment of drug‐induced seizures. British journal of clinical pharmacology 2016;81(3):412-19. doi: D O I : 1 0 . 1 1 1 1 / b c p . 1 2 7 2 0
  37. Reed G. Does digoxin cause more harm than good? Journal of Paramedic Practice 2019;11(4):165-70. doi:
  38. Karthikeyan G, Devasenapathy N, Zühlke L, et al. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry. Heart 2019;105(5):363-69.
  39. Dasgupta A. Therapeutic Drug Monitoring of Digoxin. Toxicological reviews 2006;25(4):273-81. doi: 10.2165/00139709-200625040-00007